[1]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[2]MA LN, HE ZM, CAO ZH, et al.Relationship between liver pathology and clinical characters in HBV carriers[J].Chin J Hepatol, 2010, 18 (6) :433-436. (in Chinese) 马丽娜, 何智敏, 曹振环, 等.乙型肝炎病毒携带者的肝脏病理学与临床特征[J].中华肝脏病杂志, 2010, 18 (6) :433-436.
|
[3]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The programme of prevention and cure for viral hepatitis[J].Chin J Hepatol, 2000, 8 (6) :324-329. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
|
[4]WONG GL, CHAN HL, MAK CW, et al.Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis[J].Hepatology, 2013, 58 (5) :1537-1547.
|
[5]HOSAKA T, SUZUKI F, KOBAYASHI M, et al.Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection[J].Hepatology, 2013, 58 (1) :98-107.
|
[6]DOU XG.Anti-virus treatment strategies for chronic hepatitis Bvirus infection with normal alanine aminotransferase[J].Chin JPract Intern Med, 2013, 33 (6) :454-456. (in Chinese) 窦晓光.丙氨酸转氨酶正常的慢性乙型肝炎病毒感染人群抗病毒治疗策略[J].中国实用内科杂志, 2013, 33 (6) :454-456.
|
[7]MORIYANA M, HAYASHIDA JN, TOYOSHIMA T, et al.Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sj9gren's syndrome[J].Clin Exp Immunol, 2012, 169 (1) :17-26.
|
[8]LAI M, HYATT BJ, NASSER I, et al.The clinical significance of persistently normal ALT in chronic hepatitis B infection[J].J Hepatol, 2007, 47 (6) :760-767.
|
[9]YUEN MF, YUAN HJ, WONG DK, et al.Prognostic determinants for chronic hepatitis B in Asians:therapeutic implications[J].Gut, 2005, 54 (11) :1610-1614.
|
[10]ZHOU P, SUN HL, ZHU XH.Relationship between serum HBVDNA loads and hepatic pathological changes in patients with mild chronic hepatitis B[J].J Pract Hepatol, 2014, 17 (4) :364-367. (in Chinese) 周萍, 孙慧伶, 朱肖鸿.慢性乙型肝炎患者血清HBV DNA载量与肝组织病理学变化关系研究[J].实用肝脏病杂志, 2014, 17 (4) :364-367.
|
[11]CUI XP, XIE QX, JIANG XP, et al.Pathological changes of liver tissues in 486 patients with chronic hepatitis B[J].J Pract Hepatol, 2015, 18 (4) :360-363. (in Chinese) 霍雪平, 谢琴秀, 江晓平, 等.486例慢性乙型肝炎患者肝组织病理学变化与肝功能指标的相关性研究[J].实用肝脏病杂志, 2015, 18 (4) :360-363.
|
[12]TAN YW, SHI ZQ, YU XJ, et al.Pathological analysis of liver tissues from chronic hepatitis B patients with normal alanine aminotransferase levels[J].Chin J Infect Dis, 2010, 28 (6) :354-358. (in Chinese) 谭友文, 史正全, 於学军, 等.丙氨酸转氨酶正常的慢性乙型肝炎病毒感染者的肝脏病理学分析[J].中华传染病杂志, 2010, 28 (6) :354-358.
|
[13]GENG XX, LIN JM, YANG XX, et al.Liver histopathology and clinical manifestations between HBe Ag-positive and-negative patients with chronic HBV infection and mildly elevated ALT level (less than two-time up limit of normal) :an analysis of 196 cases[J].World Chin J Dig, 2013, 21 (17) :1607-1615. (in Chinese) 耿晓霞, 林健梅, 杨兴祥, 等.ALT小于2倍正常上限的HBe Ag+/-慢性HBV感染者肝脏病理及临床分析196例[J].世界华人消化杂志, 2013, 21 (17) :1607-1615.
|
[14]CHEN XF, CHEN XP, MA XJ, et al.Liver pathologic changes in chronic Hepatitis B patients with mildly elevated serum alanine aminotransferase levels after two-year followed-up[J].J Pract Hepatol, 2015, 18 (6) :594-597. (in Chinese) 陈学福, 陈小苹, 马晓军, 等.低丙氨酸氨基转移酶慢性乙型肝炎患者肝组织病理学变化及其影响因素分析[J].实用肝脏病杂志, 2015, 18 (6) :594-597.
|
[15]ALAM S, AHMAD N, MUSTAFA G, et al.Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B[J].Liver Int, 2011, 31 (6) :826-830.
|
[16]CHEN L, ZHOU XB, WEN DF, et al.Clinical features and liver pathology in chronic hepatitis B virus-infected patients with normal liver function[J].J Clin Hepatol, 2015, 31 (9) :1430-1433. (in Chinese) 陈丽, 周兴蓓, 温丹凤, 等.肝功能正常的慢性HBV感染者的临床特征及肝脏病理学分析[J].临床肝胆病杂志, 2015, 31 (9) :1430-1433.
|
[17]MORGAN M, KEEFE EB.Diagnosis and treatment of chronic hepatitis B:2009 update[J].Minerva Gastroenterol Dietol, 2009, 55 (1) :5-22.
|
[18]MARTINOT-PEIGNOUX M, LAPALUS M, ASSELAH T, et al.HBs Ag quantification:useful for monitoring natural history and treatment outcome[J].J Hepatol, Liver Int, 2014, 34 (Suppl 1) :97-107.
|
[19]XU KH, ZHANG L, CHEN JS, et al.Clinical and liver histological analysis of chronic hepatitis B patients with alanine aminotransferase less than two-time upper limits of normal[J].Acta Acad Med Bengbu, 2014, 39 (4) :438-441. (in Chinese) 徐葵花, 张莉, 陈家盛, 等.丙氨酸氨基转移酶低于2倍正常值上限的慢性乙型肝炎病毒感染者临床分析[J].蚌埠医学院学报, 2014, 39 (4) :438-441.
|